LISATA THERAPEUTICS, INC. Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31)
LISATA THERAPEUTICS, INC. (LSTA) reported Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) of $0 for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease · last filed 2013-05-09
- LISATA THERAPEUTICS, INC. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2012-12-31 was -$4.30M, a 1219.49% decline year-over-year.
- LISATA THERAPEUTICS, INC. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2012-09-30 was -$50.13K, a 102.35% decline year-over-year.
- LISATA THERAPEUTICS, INC. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2012-06-30 was -$134.41K.
- LISATA THERAPEUTICS, INC. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2012 was -$4.15M, a 259.30% decline from fiscal 2011.
- LISATA THERAPEUTICS, INC. other comprehensive income (loss), net of tax (deprecated 2012-01-31) for fiscal 2011 was $2.61M.
| Period end | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 12 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 12 month as first filed |
|---|---|---|---|---|---|
| 2013-03-31 | $0.00 10-Q · filed 2013-05-09 | -$4.30M derived: sum of 2 quarters · filed 2013-05-09 | -$4.35M derived: sum of 3 quarters · filed 2013-05-09 | -$4.48M derived: sum of 4 quarters · filed 2013-05-09 | |
| 2012-12-31 | -$4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | -$4.35M derived: sum of 2 quarters · filed 2013-03-11 | -$4.48M derived: sum of 3 quarters · filed 2013-03-11 | -$4.15M 10-K · filed 2013-03-11 | |
| 2012-09-30 | -$50.13K 10-Q · filed 2012-11-13 | -$184.54K derived: sum of 2 quarters · filed 2012-11-13 | $147.30K 10-Q · filed 2012-11-13 | $361.38K derived: sum of 4 quarters · filed 2013-05-09 | |
| 2012-06-30 | -$134.41K 10-Q · filed 2012-08-14 | $197.43K 10-Q · filed 2012-08-14 | $411.51K derived: sum of 3 quarters · filed 2013-05-09 | $2.55M derived: sum of 4 quarters · filed 2013-05-09 | |
| 2012-03-31 | $161.85K 10-Q · filed 2013-05-09 | $545.92K derived: sum of 2 quarters · filed 2013-05-09 | $2.68M derived: sum of 3 quarters · filed 2013-05-09 | $1.25M derived: sum of 4 quarters · filed 2013-05-09 | |
| 2011-12-31 | $384.07K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $2.52M derived: sum of 2 quarters · filed 2013-03-11 | $1.09M derived: sum of 3 quarters · filed 2013-03-11 | $2.61M 10-K · filed 2013-03-11 | $2.60M 8-K · filed 2012-08-15 |
| 2011-09-30 | $2.13M 10-Q · filed 2012-11-13 | $704.90K derived: sum of 2 quarters · filed 2012-11-13 | $2.22M 10-Q · filed 2012-11-13 | ||
| 2011-06-30 | -$1.43M 10-Q · filed 2012-08-14 | $88.21K 10-Q · filed 2012-08-14 | |||
| 2011-03-31 | $1.52M 10-Q · filed 2012-05-11 | ||||
| 2010-12-31 | $2.84M 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |